Lead Story: Thirty Years of The ASAM Criteria: A Report Card

Lead Story: Thirty Years of The ASAM Criteria: A Report Card

Imagine having a blueprint that has shaped addiction treatment for over 30 years. That's exactly what the ASAM Criteria have done. In this episode of 'This Week in Addiction Medicine', we dive into the extensive history and significant impact of this sophisticated system. The ASAM Criteria have set a national standard for organizing addiction treatment services, guiding everything from patient care decisions to the types and intensity of treatments offered.

Beyond the Criteria, the episode explores ASAM CONTINUUM software and the ASAM-CARF Level of Care Certification Program, which have provided a common language and process for enhancing care across the board. But it's not all about past achievements; there's also a focus on future improvements in addiction treatment. The episode tackles several pressing issues, including how cannabis legalization affects pharmaceuticals, strategies for dosing buprenorphine and methadone in opioid use disorder, and the link between alcohol consumption and cancer risk.

You'll also hear about the motivations behind non-prescribed buprenorphine use, barriers to accessing substance use treatment, and the importance of balanced science communication around psychedelics. Additional discussions cover EEG biomarkers for fentanyl's effects and how marijuana use might be connected to cardiac arrhythmias. Whether you're a healthcare professional, a student, or someone touched by addiction, this episode is packed with insights that can help you understand and navigate the complex world of addiction medicine.